Immunitybio Inc. (IBRX)
$6.2
Immunitybio Inc. (IBRX) Share Price Forecast
Currently 8 wall-street analysts regularly analyze the financials of Immunitybio Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Immunitybio Inc. (IBRX) have a share price target of $7.5. This median of share price forecast represents a 20.97% upside from the latest price of $6.2 as on 04.06.24.
Immunitybio Inc. (IBRX) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Immunitybio Inc. (IBRX) share price will touch around $7.5 in next 12-months.
Immunitybio Inc. (IBRX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Immunitybio Inc.'s share price and its median forecast price. As on 04.06.24, the difference is 13.87%
Immunitybio Inc. (IBRX): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Immunitybio Inc. (IBRX) Share Price : Analyst Recommendation
Based on 8 analysts tracking and researching Immunitybio Inc. (IBRX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 0 | 0 | 3 |
| Outperform | 0 | 0 | 3 |
| Hold | 3 | 3 | 2 |
| Underperform | 2 | 2 | 0 |
| Sell | 1 | 1 | 0 |
Immunitybio Inc. (IBRX) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Immunitybio Inc. (IBRX) is $7.5, offered by 8 analysts offering 12-month price forecasts.
Immunitybio Inc. (IBRX) has a maximum of 0.21 upside potential, based on 8 analysts offering 12-month price forecasts.
Based on 8 analysts tracking and researching Immunitybio Inc. (IBRX), 75% have a buy recommendation. Remaining 25% have either sell or hold recommendations.
The latest share price of Immunitybio Inc. (IBRX) is $6.2 as of 04/06/2024.
6 of total 8 analysts offering stock ratings for Immunitybio Inc. IBRX have recommended buy rating.
₹0 US Stocks a/c Opening Fee